You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinomas, Non-Small-Cell Lung

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

KRAS Gene Mutation Trial in Cincinnati, Dallas (TVB-2640)

Recruiting
  • KRAS Gene Mutation
  • Cincinnati, Ohio
  • +1 more
Dec 19, 2022

Lung Tumor Protein Synthesis Rates in Lung Cancer Patients

Recruiting
  • Lung Cancer
  • There are no interventions in the present study
  • Heerlen, Limburg, Netherlands
    Zuyderland Medical Center
Mar 31, 2023

NSCLC, Non-Small Cell Lung Carcinoma, NSCLC Trial run by the National Cancer Institute (NCI) (biological, drug, device)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Montanide (Registered Trademark) ISA-51 VG Adjuvant
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Lung Sarcomatoid Carcinoma Trial in Beijing, Shanghai (Savolitinib)

Active, not recruiting
  • Lung Sarcomatoid Carcinoma
  • Beijing, Beijing, China
  • +1 more
Nov 29, 2021

Advanced Solid Tumors, Gastric Cancer, Gastroesophageal Junction Cancer Trial in Japan, United States (PF-07265028, Sasanlimab)

Recruiting
  • Advanced Solid Tumors
  • +5 more
  • Scottsdale, Arizona
  • +7 more
Jan 23, 2023

Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Chiba, Tokyo (RO7616789, Tocilizumab)

Recruiting
  • Small Cell Lung Cancer
  • Neuroendocrine Carcinoma
  • Chiba, Japan
  • +1 more
Jan 16, 2023

Small Cell Lung Cancer Trial in Nice (acetazolamide in combination with platinum and etoposide-based radiochemo)

Recruiting
  • Small Cell Lung Cancer
  • acetazolamide in combination with platinum and etoposide-based radiochemotherapy
  • Nice, France
    Centre Antoine Lacassagne
Jan 19, 2023

Small Cell Lung Cancer, Extra-Pulmonary Small Cell Carcinomas Trial run by the NCI (PLX038, Rucaparib)

Active, not recruiting
  • Small Cell Lung Cancer
  • Extra-Pulmonary Small Cell Carcinomas
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Double-dose Furmonertinib in Treatment of Slow

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • (no location specified)
Oct 31, 2023

NSCLC Trial in Shanghai

Not yet recruiting
  • Non-small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Jul 20, 2023

    NSCLC, EGFR Gene Mutation, EGFR-TKI Resistant Mutation Trial (Nintedanib, gefitinib, erlotinib, afatinib)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +2 more
    • Nintedanib, gefitinib, erlotinib, afatinib
    • (no location specified)
    Oct 2, 2023

    NSCLC, Neoadjuvant Therapy, Radiotherapy Trial in Yangzhou (drug, radiation, other)

    Recruiting
    • Non-small Cell Lung Cancer
    • +3 more
    • Yangzhou, Jiangsu, China
      People's hospital of northern jiangsu
    Sep 26, 2023

    Stage II-IIIB(N2) NSCLC Trial in Shanghai (TQB2450, Carboplatin, Pemetrexed)

    Not yet recruiting
    • Stage II-IIIB(N2) Non-small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Oct 26, 2023

    Specific Protein Overexpression in Adult Non-Small Cell Lung

    Not yet recruiting
    • Non Small Cell Lung Cancer
      • (no location specified)
      Sep 29, 2023

      Identify Resected Non-small-cell Lung Cancer With High Risk of

      Recruiting
      • Non-small Cell Lung Cancer Stage IIIA
      • Resected non small cell lung cancer
      • Toulouse, France
        Julien MAZIERES
      Feb 8, 2023

      NSCLC Trial (Tirelizumab;Chemotherapy monotherapy)

      Not yet recruiting
      • Non-small Cell Lung Cancer
      • Tirelizumab；Chemotherapy monotherapy
      • (no location specified)
      Jul 27, 2023

      NSCLC Trial (BGB-A445, Docetaxel, Tislelizumab)

      Not yet recruiting
      • Non-Small Cell Lung Cancer
      • (no location specified)
      Sep 6, 2023

      TRAcking Non-small Cell Lung Cancer Evolution Through Therapy

      Not yet recruiting
      • Lung Cancer, Non-small Cell
      • Small Cell Lung Cancer
        • (no location specified)
        Nov 16, 2022

        NSCLC Trial in Wuhan (Cadonilimab, Pemetrexed, Carboplatin)

        Recruiting
        • Carcinoma, Non-Small-Cell Lung
        • Wuhan, Hubei, China
          Qian Chu
        Aug 18, 2023

        NSCLC Trial in Rockville (Crizotinib - Usual, Crizotinib - Study)

        Not yet recruiting
        • Non-Small Cell Lung Cancer
        • Crizotinib - Usual
        • Crizotinib - Study
        • Rockville, Maryland
          Medicine Invention Design, Inc. - IORG0007849
        Oct 5, 2023

        Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in

        Not yet recruiting
        • Metastatic Lung Non-Small Cell Carcinoma
        • +2 more
        • Cetuximab
        • +2 more
        • Sacramento, California
          University of California Davis Comprehensive Cancer Center
        Oct 2, 2023

        NSCLC Trial in Beijing

        Recruiting
        • NSCLC
          • Beijing, China
            Yuyan Wang
          Oct 10, 2023

          NSCLC Trial in Shanghai (SI-B001, SI-B003)

          Not yet recruiting
          • Non-small Cell Lung Cancer
          • Shanghai, Shanghai, China
            Shanghai Pulmonary Hospital
          Jul 10, 2023

          EGFR-Mutated Non-Small-Cell Lung Carcinoma, Small Cell/Neuroendocrine Trial run by the National Cancer Institute (NCI)

          Recruiting
          • EGFR-Mutated Non-Small-Cell Lung Carcinoma
          • Small Cell/Neuroendocrine
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Jan 20, 2023

          NSCLC Trial in Guangzhou (BL-M07D1)

          Not yet recruiting
          • Non-small Cell Lung Cancer
          • Guangzhou, Guangdong, China
            Sun Yat-sen University Cancer Center
          Nov 1, 2023